Where Strategic IP Decisions Matter Most

Hylton-Rodic Law is a Washington, D.C.–based intellectual property firm.
We work with innovative companies in scientifically complex industries, where intellectual property decisions shape commercialization, competitive advantage, investment, market access, and long-term business success. Although the technologies differ, the challenge is often the same: making strategic IP decisions today that continue to support the business tomorrow.

  • Chemistry-Driven, Materials & Advanced Technologies

    Polymers, specialty chemicals, advanced materials, battery technologies, food science

  • Life Sciences

    Biotechnology, diagnostics, personalized medicine

  • Medical Devices & Diagnostics

    Medical devices, diagnostics, integrated technologies

  • Pharmaceuticals & Therapeutics

    Drug discovery, formulations, delivery systems

  • Startups & Emerging Companies

    Strategic IP guidance from early innovation through commercialization

  • Universities & Technology Transfer

    Supporting research commercialization, licensing, and technology transfer

Explore Our Industry Experience

Featured Insights

  • How Should Your IP Strategy Evolve as AI Accelerates Drug Discovery?

    • AI is transforming how new therapies are discovered. Explore strategic perspectives on protecting innovation while supporting long-term commercial growth.

  • Could Existing Patents Delay Your Next Product Launch?

    • A Freedom-to-Operate (FTO) analysis can help identify potential patent risks before commercialization, supporting more informed business decisions.

  • Will Your Patent Portfolio Support Your Business as It Grows?

    • Strong IP strategy extends beyond patent filings. Learn how thoughtful portfolio planning can strengthen commercialization, partnerships, and long-term growth.

Visit the Newsroom →